BALFX
Price
$34.82
Change
-$0.05 (-0.14%)
Updated
May 23 closing price
Net Assets
237.69B
ETNMX
Price
$14.25
Change
-$0.01 (-0.07%)
Updated
May 23 closing price
Net Assets
378.77M
Interact to see
Advertisement

BALFX vs ETNMX

Header iconBALFX vs ETNMX Comparison
Open Charts BALFX vs ETNMXBanner chart's image
American Funds American Balanced F1
Price$34.82
Change-$0.05 (-0.14%)
VolumeN/A
Net Assets237.69B
Eventide Balanced Fund
Price$14.25
Change-$0.01 (-0.07%)
VolumeN/A
Net Assets378.77M
BALFX vs ETNMX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BALFX vs. ETNMX commentary
May 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BALFX is a Buy and ETNMX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BALFX has more cash in the bank: 238B vs. ETNMX (379M). BALFX pays higher dividends than ETNMX: BALFX (1.95) vs ETNMX (1.81). BALFX was incepted earlier than ETNMX: BALFX (24 years) vs ETNMX (10 years). ETNMX (1.09) is less costly to investors than BALFX (0.61). BALFX (44.00) and ETNMX (43.00) have comparable annual turnover. BALFX has a lower initial minimum investment than ETNMX: BALFX (250) vs ETNMX (1000). ETNMX annual gain was more profitable for investors over the last year : 5.11 vs. BALFX (4.73). ETNMX return over 5 years is better than : 40.38 vs. BALFX (37.91).
BALFXETNMXBALFX / ETNMX
Total Expense Ratio0.611.0260%
Annual Report Gross Expense Ratio0.611.0956%
Fund Existence24 years10 years-
Gain YTD1.9691.139173%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets238B379M62,797%
Annual Yield % from dividends1.951.81108%
Returns for 1 year4.735.1192%
Returns for 3 years22.4919.59115%
Returns for 5 years37.9140.3894%
Returns for 10 years52.16N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SAMG14.40N/A
N/A
Silvercrest Asset Management Group
CLS114.03N/A
N/A
Celestica
APPN31.12N/A
N/A
Appian Corp
ARKO4.73N/A
N/A
ARKO Corp
SBFM1.40-0.02
-1.41%
Sunshine Biopharma Inc